The peak endocardial acceleration (PEA) caused by ventricular isometri
c contraction can be measured with an implantable microaccelerometer l
ocated inside the tip of a normal unipolar pacing lead. If has been sh
own that PEA correlates with myocardial contractility and the maximum
rate of rise of ventricular pressure (peak dP/dt) of the left ventricl
e. A PEA measuring system was temporarily inserted into the apex of th
e right ventricle in seven patients affected by syncope of uncertain o
rigin. Each patient subsequently underwent 60 degrees tilt testing wit
h three different protocols: without pharmacological challenge (baseli
ne); potentiated with sublingual trinitroglycerin (at a dose of 0.3 mg
), and with isoproterenol infusion (at a dose of 3 mu g/min). Each pha
se lasted 20 minutes. Syncope was induced in I patient during the base
line phase, in 3 patients during the trinitrin phase, and in 4 patient
s during the isoproterenol phase. Six patients had a negative response
during the baseline phase and served as a control group. From the beg
inning of upright posture to the time of maximum heart rate, PEA incre
ased by about the same amount in both positive and negative patients,
but absolute values were from two- to three fold higher with isoproter
enol (from 1.2 +/- 0.5 G to 1.6 +/- 0.8 G, from 0.8 +/- 0.2 G to 1.2 /- 0.4 G, and from 2.8 +/- 1.8 G to 3.6 +/- 1.8 G, respectively, for n
egative, positive baseline or trinitrin, and positive isoproterenol te
sts). At the time of syncope, PEA values fell to baseline values. PEA
changes were inversely correlated with blood pressure changes and dire
ctly correlated with heart rate changes. Thus, tilt induced syncope oc
curred both at low and high levels of left ventricular contractility.
Whether spontaneous syncopes occur at low or high PEA behavior remains
to be established. Since heart rate correlates well with changes in P
EA and is far easier to measure, it is unlikely that a PEA measurement
system or, in general, a contractility-based system, might become an
ideal sensing parameter for the introduction of devices to combat vaso
vagal syncope.